Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.

Govindan R, Kratzke RA, Herndon JE, Niehans GA, Vollmer R, Watson D, Green MR, Kindler HL. Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. Clin Cancer Res. 2005 Mar 15; 11(6):2300-4.

View in: PubMed

collapse authors with profiles